Keytruda could boost economy

Posted 22 November 2021 AM

A new report, commissioned by MSD, projects the potential that anti PD-1/PD-L1 inhibitors could have beyond improving survival, if used in all eligible Australian cancer patients.

The Health Impact Projection (HIP) 2.0 analysis, which estimated the benefit derived from helping patients stay in the workplace, stay out of hospital and contribute to their communities and the economy, highlights the importance of policy work to provide faster access to these cancer treatments.

To see the whole article, please login